Literature DB >> 879956

Nephropathy associated with methicillin therapy. Prevalence and determinants in patients with staphylococcal bacteremia.

C M Nolan, R S Abernathy.   

Abstract

The nephropathy associated with methicillin sodium therapy is considered to be rare, but its prevalence is unknown. We reviewed the antibiotic therapy of 81 cases of Staphylococcus aureus bacteremia to establish the frequency and determinants of methicillin nephropathy in that disease. Fifty-two patients received methicillin; nine (17%) experienced the characteristic clinical signs previously associated with drug-induced acute interstitial nephritis. This nephropathy uniformly subsided after methicillin was withdrawn, and did not always include deterioration of renal function. Factors that correlated with methicillin nephropathy were endocarditis and prolonged treatment, but not intravenous drug abuse. There was only one adverse reaction among 29 patients treated with a cephalosporin. It was similar to the nephropathic reactions to methicillin. Thus, reversible renal abnormalities are prevalent during methicillin therapy, particularly among patients with staphylococcal infections such as endocarditis. When prolonged therapy with methicillin is required, the urinary sediment and renal excretory function should be monitored.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879956

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

1.  [Acute tubulointerstitial nephritis as hyperergic reaction of the kidneys].

Authors:  A Schwarz; J U Becker; H Haller
Journal:  Internist (Berl)       Date:  2012-08       Impact factor: 0.743

Review 2.  Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  E Saltiel; R N Brogden
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

Review 3.  [Interstitial nephritis].

Authors:  J Halbritter; C Mayer; F M Rasche; K Amann; T H Lindner
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

4.  Clinical value of teichoic acid antibody titers in the diagnosis and management of the staphylococcemias.

Authors:  A S Bayer; D B Tillman; N Concepcion; L B Guze
Journal:  West J Med       Date:  1980-04

5.  Nafcillin therapy for Staphylococcus aureus endocarditis.

Authors:  H Masur; H W Murray; R B Roberts
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

6.  Absence of nafcillin-associated nephritis. A prospective analysis of 210 patients.

Authors:  S L Barriere; J E Conte
Journal:  West J Med       Date:  1980-12

7.  Clinical, Pathological, and Prognostic Characteristics of Glomerulonephritis Related to Staphylococcal Infection.

Authors:  Si-Yang Wang; Ru Bu; Qi Zhang; Shuang Liang; Jie Wu; Xue-Guang Zhang Shu-Wen Liu; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  Cefazolin-Related Acute Interstitial Nephritis with Associated Nephrotic-Range Proteinuria: A Case Report.

Authors:  Ang Xu; David Hyman; Lee Bach Lu
Journal:  Drug Saf Case Rep       Date:  2018-04-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.